Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva to shutter Israeli R&D site in company reorganization | Fierce Biotech
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Israel's Teva gives upbeat outlook as restructuring proceeds | The Seattle Times
Teva to eliminate 14,000 jobs, close facilities, in major restructuring - Philadelphia Business Journal
Teva cut to Sell at UBS citing uncertainty over leadership transition (NYSE: TEVA) | Seeking Alpha
Teva sells remaining women's health assets
Teva Lands A CEO: Can Schultz Replicate Lundbeck Success? :: Scrip
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Teva наконец-то выбрала нового исполнительного директора | МОСМЕДПРЕПАРАТЫ
Teva to cut 14,000 jobs | Business | Chemistry World
Новым гендиректором Teva станет Коре Шульц – журнал Vademecum
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharm expects to start paying US opioid settlement in 2023 - CNA
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
Israeli drugmaker Teva to cut quarter of global work force | The Seattle Times
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Коре Шульц: «Teva планирует выводить на рынок новые препараты каждые год-два» - Ведомости
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health
Loss-making Teva Progresses Turnaround | CHEManager
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
Teva scales down Japanese operations - Globes
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | Business
Teva rewards CEO Schultz with $4M equity pay bump after companywide cutbacks | Fierce Pharma
